Clinical Trial Update: A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy of an 11-valent pneumococcal vaccine against otitis media in children was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• Pneumococcal 11-valent vaccine (pneumococcal conjugate vaccine (11-valent))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis A | Phase 3 | Status: TERMINATED